MEAGHAN GUSTAFSON: Open Payments
NPI 1366223729 · JOPLIN, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,099 in 67 payments from 14 companies in 2025. Trend: 2023 $186 · 2024 $1,345 · 2025 $1,099
Food & beverage: $1,099
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $185 |
| Lilly USA, LLC | 10 | $163 |
| Amgen Inc. | 11 | $147 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $146 |
| Dexcom, Inc. | 4 | $87 |
| Novo Nordisk Inc | 5 | $86 |
| Merck Sharp & Dohme LLC | 4 | $69 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $58 |
| GlaxoSmithKline, LLC. | 3 | $44 |
| ABBVIE INC. | 2 | $36 |
Products named: BREZTRI, MOUNJARO, JARDIANCE, Dexcom G6 Transmitter, REPATHA, CAPVAXIVE, Ozempic, TRINTELLIX.
Industry payments across MO — which companies pay providers there.
